CEO
Expert Biopharma
Material Science Technician
Expert Cellular Biology
Expert Clinical Pathway
CFO
Le stage portera sur la mesure de l’adhésion et de l’activation plaquettaires, en statique puis sous flux. Au-delà de l’activation réversible, il quantifiera les plaquettes ayant basculé en zone irréversible (dégranulation) et les plaquettes pro-coagulantes (PS+, phosphatidylsérine exposée), en imagerie de surface (immunofluorescence, MEB) et en cytométrie sur l’effluent, sur différents revêtements.
Learn MoreLe stage, centré sur les cellules endothéliales, articule trois volets complémentaires : (1) la mise au point d’un test de cytotoxicité et de biocompatibilité (esprit ISO 10993-5) sur plusieurs types cellulaires ; (2) la validation d’un panel de fonctionnalité endothéliale (KLF4/eNOS) ; (3) la mesure de l’index physiologique de l’endothélium sous flux. L’objectif est d’anticiper, sur cellules, des questions aujourd’hui tranchées au stade animal.
Learn MoreLe stage articule trois volets complémentaires, en lien avec les prestataires, les investigateurs et les autorités : (1) l’évaluation biologique et la caractérisation chimique du dispositif revêtu ; (2) la construction du dossier réglementaire et de sa traçabilité ; (3) la préparation réglementaire et clinique de la première étude dans l’humain (First-in-Human, FIH).
Learn MoreConsultant cardiologist at AP-HP Bichat-Beaujon hospitals, INSERM Research Director and head of the “Cardiovascular Immunobiology” team at the UMRS Inserm/Paris Cité and Sorbonne Paris Nord Universities - Laboratory of Vascular Translational Science (Paris)
Dr Caligiuri is an accomplished cardiologist and a senior scientist with a deep understanding of basic cardiovascular and immunology research. As an expert in the regulation of the blood/vessel interface, she is committed to developing science-driven solutions that improve cardiac and immuno-inflammatory pathologies. She is co-inventor of the CD31 technology, and a reference author in the field.
Interventional cardiologist, co-Director of Cardiology Unit at Medipôle (Lyon-Villeurbanne)
Professor Jacques Monségu is Knight of the Legion of Honor, Officer of the National Order of Merit and Knight of Academic Palms. French military physician, Professor in 2001, he worked at the Val-de-Grâce Military Hospital in Paris until 2013 and was director of the Cardiology Unit. then at Institut Mutualiste Montsouris in Paris. Since 2015, he is Head of the Cardiovascular Institute at Groupe Hospitalier Mutualiste of Grenoble. Prof. Jacques Monségu has a very high interest in clinical research and has actively participated in Radial teaching in France and in Europe. He is Proctor of the Course on Radial approach on PCR edu online, and Board Member at the Groupement de Réflexion sur la Cardiologie Interventionnelle (GRCI).
Interventional cardiologist, PU-PH in cardiology specializing in coronary disease at CHU Grenoble
Professor Gilles Barone-Rochette is a Board Member of the Société Française de Cardiology and Member of the GACI and FACT network, with large expertise in invasive (endocoronary imaging and coronary physiology) and non-invasive (echography, cardiac CT and MRI, nuclear medicine) imaging techniques, for which he has been trained in particular to implant innovative medical devices (coronary stents, Reducer, etc.). Head of the cardiology department's research unit, he is also a teacher-researcher attached to the UMR INSERM 1039 research unit.
Established Professor of Interventional Medicine & Innovation, University of Galway
A world-renowned expert in interventional cardiology and imaging with over four decades of experience in clinical trials and innovation. He has pioneered several interventional procedures and devices such as BMS, DES, BRS and TAVI. He is currently an Established Professor of Interventional Medicine & Innovation at the National University in Galway (Ireland) and honorary Professor of Cardiology at NHLI, Imperial College in London.
🏆 AlchiMedics won the $25,000 Grand Prize of the GMIS 2026 Shark Tank in Tbilisi with our CD31 mimicking technology!
Read More🎥 By coating implantable devices with a #biomimetic surface that resembles the inner wall of a natural artery, we open the door to drug-free vascular healing.
Read More⚡ En 2006, la Thrombose Tardive a marqué un tournant en cardiologie interventionnelle, révélant un risque vital lié aux stents actifs. La technologie d'Electro-Greffage inventée au CEA est née d'une crise.
Read MoreCe lieu, qui fonctionne comme un incubateur, permet aux entreprises d’avoir accès à des laboratoires, et d’être accompagnées dans leur développement.
Read More📆 👨⚕️ Venez découvrir la technologie de coating d'AlchiMedics et le stent HT Supreme qui la porte au Congrès GRCI PorteMaillot, du 25 au 27 sept. 2024 !
Read More🥁 📣 Meet us on Monday Sept.23 at 10:45 ⏰ in Session 3 of the Vulnerable Plaque & Patient Meeting for a groundbreaking pitch! ✨
Read More🤩🚀🥳 So great! We are so proud to power the#HTSupreme drug eluting stent with our#BiodeG coating technology, targeting early healing for the utmost benefit of#PatientSafety, and now implanted in 1.8 million patients worldwide! 🌎
Read More🤔 Vous êtes-vous déjà demandé pourquoi notre sang ne coagule pas dans nos #arteres? 💡 Nous oui ! Et nous avons utilisé les ruses de Mère Nature pour réaliser le #camouflage de tout #implant au contact du sang ! 🤩
Read More🔔 📣 ⏱ Join us in #Paris on May 22-25 at Viva Technology, Europe’s biggest startup and tech event! We’ll be showcasing our groundbreaking #CD31 technology, targeting to solve the 50 year old problem of the management of #thrombosis vs #ischemia in #InterventionalCardiology !
Read More🚨🥳🥉AlchiMedics S.A.S. is the 3rd Prize #winner of the #ICI2024 #InnovationAward contest, with a revolutionary solution giving the hope to significantly reduce or even eliminate #AntiPlateletTherapy 😱 by taking care of the #InflammationCascade directly at its roots at device level! ✨
Read More🥁🚨📆 SAVE THE DATE! AlchiMedics S.A.S. is selected as finalist of the #Startup competition at the #ICI2024 conference, pitching on February 25 at 16:00 on "A #CD31 coating mimicking healthy endothelium: seamless integration of Cardiovascular Devices"
Read MoreO melhor Stent Coronário para seus pacientes! 💙💚 Em Fevereiro, iremos trazer um Stent Coronário. Um breve spoiler para vocês: Se destaca ao proporcionar uma recuperação aprimorada e mais rápida. Não perca! Dia 05 de Fevereiro! 🌟
Read More🥁🥳💪 FAN-TAS-TIQUE!!! Le stent actif #HTSupreme fait une entrée remarquée pour sa première implantation en France 🤩. Nous sommes si fiers🇫🇷 de voir notre technologie Biod-eG™ en action dans le quartier ! Merci à tous les contributeurs 🚀
Read More












